CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 76,487 |
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Sale | −998 | $59.10 | $59K | 75,489 |
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Sale | −3,473 | $59.99 | $208K | 72,016 |
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Sale | −729 | $61.08 | $45K | 71,287 |
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Sale | −100 | $61.72 | $6K | 71,187 |
| 2021-04-12 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 135,005 | ||
| 2021-04-06 | Knowles Julius Director | Sale | −1,889 | $58.22 | $110K | 604,885 |
| 2021-04-06 | Knowles Julius Director | Sale | −1,233 | $58.22 | $72K | 404,452 |
| 2021-04-06 | Knowles Julius Director | Sale | −3,685 | $59.10 | $218K | 601,200 |
| 2021-04-06 | Knowles Julius Director | Sale | −2,402 | $59.10 | $142K | 402,050 |
| 2021-04-06 | Knowles Julius Director | Sale | −54 | $59.95 | $3K | 601,146 |
| 2021-04-06 | Knowles Julius Director | Sale | −35 | $59.95 | $2K | 402,015 |
| 2021-04-05 | Knowles Julius Director | Sale | −298 | $58.66 | $17K | 622,909 |
| 2021-04-05 | Knowles Julius Director | Sale | −195 | $58.66 | $11K | 416,208 |
| 2021-04-05 | Knowles Julius Director | Sale | −5,445 | $59.76 | $325K | 617,464 |
| 2021-04-05 | Knowles Julius Director | Sale | −3,551 | $59.76 | $212K | 412,657 |
| 2021-04-05 | Knowles Julius Director | Sale | −10,690 | $60.26 | $644K | 606,774 |
| 2021-04-05 | Knowles Julius Director | Sale | −6,972 | $60.26 | $420K | 405,685 |
| 2021-04-01 | Knowles Julius Director | Sale | −3,790 | $58.42 | $221K | 626,197 |
| 2021-04-01 | Knowles Julius Director | Sale | −2,472 | $58.42 | $144K | 418,353 |
Page 22 of 36 · 707 trades